Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000118 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 3, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
15,000
Total Value
$1,380,104.81
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 1, 2026 | Sale | 600 | $89.14 | $53,484.00 | 551,940 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 2,683 | $90.10 | $241,738.30 | 549,257 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 2,638 | $91.49 | $241,350.62 | 546,619 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 3,989 | $92.31 | $368,224.59 | 542,630 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 4,990 | $93.37 | $465,916.30 | 537,640 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 100 | $93.91 | $9,391.00 | 537,540 | Direct | โ | View Details |